Kinetics and prognostic value of inflammatory-sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation

Medical Science Monitor

Volumn 15, Issue 4, 2009, Pages

  Ziakas, Antonios ^a   Gavrilidis, Stavros ^a   Giannoglou, George ^a   Souliou, Efthimia ^a   Koskinas, Konstantinos ^a   Gemitzis, Konstantinos ^a   Hatzimiltiadis, Stavros ^a   Efthimiadis, George ^a   Paraskevaidis, Stelios ^a   Hatzitolios, Apostolos ^a   Savopoulos, Christos ^a   Parharidis, George ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Coronary stenting; Inflammatory sensitive proteins; Interleukin 6; White blood cell count

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; FIBRINOGEN; HAPTOGLOBIN; INTERLEUKIN 6; OROSOMUCOID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE; MALE; RESTENOSIS; STABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; FIBRINOGEN; HUMANS; INTERLEUKIN-6; KINETICS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STENTS;

EID: 65949124030     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med, 1999; 340: 115-126
2. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation, 2002; 105(9): 1135-1143
3. Li JJ, Nie SP, Zhang CY et al: Is inflammation a contributor for coronary stent restenosis? Medical Hypotheses, 2007; 68: 945-951 (Pubitemid 46274028)
4. Ridker PM, Rifai N, Rose L et al: Comparison of C reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347(20): 1557-1565
5. Sattar N, Gaw A, Scherbakova O et al: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 2003; 108(4): 414-419
6. Myers GL, Rifai N, Tracy RP et al: CDC; AHA.CDC/AHA workshop on markers of inflammation and cardiovascular disease. Circulation, 2004; 110: e545-49
7. Otsuka M, Hayashi Y, Ueda H et al: Predictive value of preprocedural fibrinogen concerning coronary stenting. Atherosclerosis, 2002; 164(2): 371-378
8. Germing A, Von Dryander S, Machraoui S et al: Hyperfibrinogenemia increases the risk of cardiac event after coronary artery stenting. Heart Vessels, 2000; 15(6): 263-267
9. Rahel BM, Visseren FL, Suttorp MJ et al: Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res, 2003; 60(1): 136-140
10. Chew DP, Bhatt DL, Robbins MA et al: Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation, 2001; 104(9): 992-997
11. Buffon A, Liuzzo G, Biasucci LM et al: Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol, 1999; 34(5): 1512-1521
12. Gaspardone A, Crea F, Versaci F et al: Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol, 1998; 82(4): 515-518
13. Versaci F, Gaspardone A, Tomai F et al: Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol, 2000; 85(1): 92-5, A8
14. Heeschen C, Hamm CW, Bruemmer J, Simoons ML: Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol, 2000; 35(6): 1535-1542
15. Walter DH, Fichtscherer S, Britten MB et al: Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. Am Coll Cardiol, 2001; 38(7): 2006-2012 (Pubitemid 33116578)
16. Zhou YF, Csako G, Grayston JT et al: Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. Am J Cardiol, 1999; 84(5):595-598
17. De Winter RJ, Koch KT, van Straalen JP et al: C-reactive protein and coronary events following percutaneous coronary angioplasty. Am J Med, 2003; 115(2): 85-90
18. Segev A, Kassam S, Buller CE et al: Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J, 2004; 25(12): 1029-1035
19. Gomma AH, Hirschfield GM, Gallimore JR Jr et al: Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J, 2004; 147(6): 1071-1077
20. Gurm HS, Bhatt DL, Gupta R et al: Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J, 2003; 146(4): 692-698
21. Gurm HS, Bhatt DL, Lincoff AM et al: Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart, 2003; 89(10): 1200-1204 (Pubitemid 37164014)
22. Rajagopal V, Gurm HS, Bhatt DL et al: Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. Am J Cardiol, 2004; 94(2): 190-192
23. Bhatt DL, Chew DL, Lincoff A et al: Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol, 2003; 92(2): 136-140
24. Gaspardone A, Versaci F: Coronary Stenting and Inflammation. Am J Cardiol, 2005; 96(12A): 65L-70L
25. Dibra A, Mehilli J, Braun S et al: Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Am Heart J, 2005; 150: 344-350
26. Six AJ, Tjon RM, Buys EM et al: The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis. Thromb haemost, 1990; 64(1): 113-116
27. Schillinger M, Exner M, Mlekusch W et al: Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries. Tromb haemost, 2002; 87(6): 959-965
28. Gottsauer-Wolf M, Zasmeta G, Hornykewycz S et al: Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J, 2000; 21(14): 1152-1158
29. Almagor M, Keren A, Banai S: Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J, 2003; 145(2): 248-253
30. Aggarwal A, Schneider DJ, Sobel BE, Dauerman HL: Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting. Am J Cardiol, 2003; 92(8): 924-929
31. Saleh N, Svane B, Jensen J et al: Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J, 2005; 149(5): 876-882 (Pubitemid 40718885)
32. Liu PY, Li YH, Tsai WC et al: Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention. Eur Heart J, 2003; 24(20): 1824-1832
33. Liuzzo G, Buffon A, Biasucci LM et al: Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation, 1998; 98(22): 2370-2376
34. Caixeta AM, Brito FS Jr, Costa MA et al: Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis. Catheter Cardiovasc Interv, 2007; 69(4): 500-507
35. Miller YI, Altamentova SM, Shaklai N: Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. Biochemistry, 1997; 36: 12189-12198
36. Langlois M, Delanghe J: Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem, 1996; 46: 1589-1600
37. Freyschuss A, Stiko-Rahm A, Swedenborg J et al: Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest, 1993; 91: 1282-1288
38. Godfried SL, Deckelbaum LI: Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty. Am Heart J, 1995; 129: 203-210
39. Tardif JC, Cote G, Lesperance J et al: Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and probucol study group. N Engl J Med, 1997; 337: 365-372
40. Sánchez-Margalet V, Cubero JM, Martín-Romero C et al: Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina Clin Chem Lab Med, 2002; 40(8): 769-774
41. Farb A, Sangiorgi G, Carter AJ et al: Pathology of acute and chronic coronary stenting in humans. Circulation, 1999; 99: 44-52
42. Ikari Y, Fujikawa K, Yee KO, Schwartz SM: Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel. J Biol Chem, 2000; 275: 12799-12805
43. Ikari Y, Hashimoto H, Nakajima H, Hara K: Serum concentration of alpha1- proteinase inhibitor and alpha2-macroglobulin correlates with late lumen loss following coronary stent implantation. J Thromb Haemost, 2003; 1(1): 193-194
44. Floris G, Medda R, Padiglia A, Musci G: The physiopathological significance of caeruloplasmin. Biochem Pharmacol, 2000; 60: 1735-1741
45. Ehrenwald E, Chisolm GM, Fox PL: Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest, 1994; 93: 1493-1501
46. Lamb DJ, Leake DS: Acidic pH enables ceruloplasmin to catalyse the modification of low-density lipoprotein. FEBS Lett, 1994; 338: 122-126
47. Shukla N, Maher J, Masters J et al: Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis, 2006; 187(2): 238-250 (Pubitemid 43963031)
48. Reunanen A, Knekt P, Aaran RK: Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol, 1992; 136: 1082-1090
49. Klipstein-Grobusch K, Grobbee DE, Koster JF et al: Serum caeruloplasmin as a coronary risk factor in the elderly: the Rotterdam Study. Br J Nutr, 1999; 81: 139-144
50. Mori T, Sasaki J, Kawaguchi H et al: Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J, 1995; 129: 234-238
51. Engström G, Hedblad B, Stavenow L et al: Fatality of future coronary events is related to Inflammation-Sensitive Plasma Proteins. A population-based prospective cohort study. Circulation, 2004; 110: 27-31
52. Held C, Hjemdahl P, Hakan Wallen N et al: Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. Atherosclerosis, 2000; 148: 179-188
53. Fukuda D, Shimada K, Tanaka A et al: Circulating monocytes and instent neointima after coronary stent implantation. J Am Coll Cardiol, 2004; 43(1): 18-23
54. Baumann H, Gauldie J: Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med, 1990; 7: 147-159
55. Hojo Y, Ikeda U, Katsuki T et al: Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart, 2000; 84(1): 83-87
56. Sardella G, Mariani P, D'alessandro M et al: Early elevation of interleukin- 1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thromb Res, 2006; 117(6):659-664
57. Carr WP: The role of the laboratory in rheumatology. Acute-phase proteins: Clin Rheum Dis, 1983; 9(1): 227-239
58. Versaci F, Gaspardone A, Tomai F et al: Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol, 2002; 40(11): 1935-1942
59. Schillingers M, Exner M, Mlekusch W: Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther, 2002; 9(1): 59-66
60. Azar RR, McKay RG, Kiernan FJ et al: Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol, 1997; 80: 1476-1478
61. Goldberg A, Zinder O, Zdorovyak A et al: Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina. Am Heart J, 2003; 146: 819-823
62. Fishman DL, Leon MB, Baim DS et al: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med, 1994; 331(8): 496-501
63. Serruys PW, de Jaegere P, Kiemeneij F et al: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med, 1994; 331(8): 489-495
64. Bhargava B, Karthikeyan G, Abizaid AS, Mehran R: New approaches to preventing restenosis. BMJ, 2003; 327: 274-279
65. Kornowski R, Hong Mk, Tio FO et al: In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol, 1998; 31(1): 224-230
66. Ezhov MV, Sumarokov AB, Raimbekova IR et al: Interleukin 6 but not interleukin 10 is associated with restenosis after coronary stenting. Atherosclerosis, 2003; 169: 193-194
67. Engström G, Lind P, Hedblad B et al: Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation, 2002; 105: 2632-2637
68. Brunetti ND, Correale M, Pellegrino PL et al: Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings. Eur J Intern Med, 2007; 18(2): 109-117 (Pubitemid 46330786)
69. Roguin A, Hochberg I, Nikolsky E et al: Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol, 2001; 87: 330-332
70. Roguin A, Ribichini F, Ferrero V et al: Haptoglobin Phenotype and the Risk of Restenosis After Coronary Artery Stent Implantation. Am J Cardiol, 2002; 89: 806-810